TNF and rheumatoid arthritis: The current indication of abatacept for RA is in combination with MTX and includes patients with moderate or severe disease with inadequate response or intolerance to either synthetic Disease modifying antirheumatic drugs (DMARDs) or at least one anti- TNF- alpha agent.